ArticleCureus2025
Screening for Postpartum Post-traumatic Stress Disorder (PTSD) Using the Kurdish Version of the PTSD Checklist for DSM-5 (PCL-5).
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Retraction · 2025-12-05Concerns/Issues about Data · Concerns/Issues about Methods · Objections by Author(s) · Unreliable Results and/or Conclusions ·
- Retracted
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
INTRODUCTION AND
aimPostpartum post-traumatic stress disorder (PPTSD) is a psychiatric anxiety disorder with a set of reactions and symptoms that may develop in a woman after childbirth, and it may cause significant functional impairment. This study was conducted to estimate the prevalence of PPTSD in a sample of Kurdish women, to explore possible risk factors for the development of the disorder, and to identify the severity of post-traumatic symptoms.
methodsA cross-sectional study was conducted at Brayati Primary Health Center in Erbil, Kurdistan, Iraq, from January 2020 to January 2021. Using systematic random sampling, researchers enrolled every third woman who visited the clinic for her infant's vaccinations 50-60 days postpartum. A total of 1,301 postpartum women who met the inclusion criteria participated in the study. The prevalence of PPTSD was estimated using the Kurdish version of the Post-traumatic Stress Disorder Checklist for the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) (PCL-5). Demographic, obstetric, and symptom severity factors were then compared between women with and without a PPTSD.
resultsThe overall prevalence of PPTSD was 2.9% (95% confidence interval: 2.0-3.8%). Binary logistic regression analysis revealed several predictors of PPTSD. The strongest independent predictor was a stillbirth, which increased the odds of developing PTSD by over 120 times compared to having a live baby (OR=120.546, 95% CI: 9.606, 1512.675, p<0.001). A positive history of mental health issues was also a strong predictor, increasing the odds of postpartum PTSD by more than 15 times (OR=15.313, 95% CI: 2.933, 79.955, p=0.001). Furthermore, both complications of pregnancy and labor (OR=5.852, 95% CI: 2.208, 15.514, p<0.001) and postpartum complications (OR=7.487, 95% CI: 1.808, 30.997, p=0.005) were significant risk factors. Women aged 25 years and older were also significantly more likely to develop PTSD compared to those aged 20-24 years (OR=5.855, 95% CI: 1.678, 20.432, p=0.006). Educational level, employment, conceiving type, and mode of delivery were not associated with the prevalence of PPTSD.
conclusionsThis study found a 2.9% prevalence of PPTSD, significantly associated with a history of stillbirth, specific age groups, obstetric complications, and mental health history. Women with PPTSD reported more severe symptoms across all symptom clusters.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.